<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(13)</volume><submitter>Al-Ostoot FH</submitter><pubmed_abstract>This study explores the pharmacological potential of chalcones through a multidisciplinary approach, including synthesis, quantum theory, molecular electrostatics, and density functional theory (DFT) calculations. The synthesized compound, analyzed via single crystal X-ray diffraction, crystallized in the triclinic system (space group P-1) with C-H⋯O interactions stabilizing its structure. Hirshfeld surface analysis confirms these interactions, with H-H contacts dominating (45.1 %). Molecular electrostatics analysis reveals charge distribution, and a 3.10 eV HOMO-LUMO energy gap indicates bioactivity. Molecular docking identifies the compound (&lt;b>3a&lt;/b>) showed a maximum G&lt;sub>score&lt;/sub> of HTNF-&lt;i>α&lt;/i> (-9.81 kcal/mol); Tubulin (-7.96 kcal/mol); COX2 (-7.88 kcal/mol), EGFR (-6.72 kcal/m</pubmed_abstract><journal>Heliyon</journal><pagination>e33814</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11269856</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Structural and theoretical exploration of a multi-methoxy chalcone: Synthesis, quantum theory, electrostatics, molecular packing, DFT analysis, and in-silico anti-cancer evaluation.</pubmed_title><pmcid>PMC11269856</pmcid><pubmed_authors>Aljohani MS</pubmed_authors><pubmed_authors>Geetha DV</pubmed_authors><pubmed_authors>Sridhar MA</pubmed_authors><pubmed_authors>Alharbi HY</pubmed_authors><pubmed_authors>Khanum SA</pubmed_authors><pubmed_authors>Al-Ostoot FH</pubmed_authors><pubmed_authors>Akhileshwari P</pubmed_authors><pubmed_authors>Kameshwar VH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structural and theoretical exploration of a multi-methoxy chalcone: Synthesis, quantum theory, electrostatics, molecular packing, DFT analysis, and in-silico anti-cancer evaluation.</name><description>This study explores the pharmacological potential of chalcones through a multidisciplinary approach, including synthesis, quantum theory, molecular electrostatics, and density functional theory (DFT) calculations. The synthesized compound, analyzed via single crystal X-ray diffraction, crystallized in the triclinic system (space group P-1) with C-H⋯O interactions stabilizing its structure. Hirshfeld surface analysis confirms these interactions, with H-H contacts dominating (45.1 %). Molecular electrostatics analysis reveals charge distribution, and a 3.10 eV HOMO-LUMO energy gap indicates bioactivity. Molecular docking identifies the compound (&lt;b>3a&lt;/b>) showed a maximum G&lt;sub>score&lt;/sub> of HTNF-&lt;i>α&lt;/i> (-9.81 kcal/mol); Tubulin (-7.96 kcal/mol); COX2 (-7.88 kcal/mol), EGFR (-6.72 kcal/m</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-02T23:34:35.324Z</modification><creation>2025-04-19T13:13:06.816Z</creation></dates><accession>S-EPMC11269856</accession><cross_references><pubmed>39055829</pubmed><doi>10.1016/j.heliyon.2024.e33814</doi></cross_references></HashMap>